Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ASI-02 vs Agitated Saline for Suspected Right-to-left Shunt
NCT06938347Phase 3Recruiting
- Sponsor
- Agitated Solutions
- Start
- Nov 2025
- Primary completion
- Nov 2026
- Countries
- 2
01
Overview
A Phase 3 trial of ASI-02 in right-to-left shunt, sponsored by Agitated Solutions. Started Nov 2025; status: recruiting.
02
Drugs
ASI-02
03
Conditions
right-to-left shunt
Beyond the preview
Go deeper on NCT06938347.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06938347.